Carregant...
The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
Background: Increased understanding of the molecular causes of disease has begun to fulfill the promise of precision medicine with the development of targeted drugs, particularly for serious diseases with unmet needs. The drug approval regulatory process is a critical component to the continued grow...
Guardat en:
| Publicat a: | J Pers Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828670/ https://ncbi.nlm.nih.gov/pubmed/33466644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11010045 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|